Top Markets
#1 Wiki Cat Wiki Cat +55.96%
#2 Siren Siren +35.51%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.62%
#4 Ribbita by Virtuals Ribbita by Virtuals +23.21%
#5 PulseChain PulseChain +18.13%
#6 OpenEden OpenEden +17.79%
#7 KUB Coin KUB Coin +17.54%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.55%
#9 Cysic Cysic +15.88%
#10 The Grays Currency The Grays Currency +15.82%
Coin of the day
Wiki Cat Wiki Cat
설정
언어
한국어
통화
USD
테마
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
주식 순위 #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
주가
$0.01084256
시가총액
$13.87M
변동 (1일)
0.00%
변동 (1년)
1.70%
국가
NZ
거래 BLIS Technologies Limited (BLT)

카테고리

Healthcare
BLIS Technologies Limited (BLT)의 매출
Aug 2026 기준 매출 TTM: 0
BLIS Technologies Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
BLIS Technologies Limited의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE